D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 31,597 370 World Ranking 14045 National Ranking 585

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

Gideon M. Hirschfield spends much of his time researching Internal medicine, Primary biliary cirrhosis, Immunology, Gastroenterology and Primary sclerosing cholangitis. In his research, Predictive value of tests and Clinical trial is intimately related to Surgery, which falls under the overarching field of Internal medicine. His Primary biliary cirrhosis study combines topics from a wide range of disciplines, such as Genome-wide association study, Autoantibody, Antibody, Cirrhosis and Genotype.

Immunology is often connected to Disease in his work. His Primary sclerosing cholangitis study combines topics in areas such as Autoimmune hepatitis, Liver biopsy and Ulcerative colitis. The concepts of his C-reactive protein study are interwoven with issues in Myocardial infarction and Acute-phase protein.

His most cited work include:

  • C-reactive protein: a critical update (2819 citations)
  • C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease (2560 citations)
  • The gut microbiota and host health: a new clinical frontier (970 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Gastroenterology, Primary sclerosing cholangitis, Primary biliary cirrhosis and Immunology are his primary areas of study. His work on Ursodeoxycholic acid, Liver transplantation, Cirrhosis and Cohort is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His Liver transplantation research includes themes of Colectomy, Proportional hazards model and Hazard ratio.

As part of his studies on Gastroenterology, Gideon M. Hirschfield often connects relevant areas like Obeticholic acid. He has included themes like Colitis, Inflammatory bowel disease, Pediatrics and Ulcerative colitis in his Primary sclerosing cholangitis study. The study incorporates disciplines such as Genome-wide association study and Disease in addition to Primary biliary cirrhosis.

He most often published in these fields:

  • Internal medicine (66.06%)
  • Gastroenterology (49.36%)
  • Primary sclerosing cholangitis (41.92%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (66.06%)
  • Gastroenterology (49.36%)
  • Primary sclerosing cholangitis (41.92%)

In recent papers he was focusing on the following fields of study:

Gideon M. Hirschfield mainly investigates Internal medicine, Gastroenterology, Primary sclerosing cholangitis, Liver transplantation and Ursodeoxycholic acid. While working in this field, Gideon M. Hirschfield studies both Internal medicine and In patient. His work carried out in the field of Gastroenterology brings together such families of science as Proportional hazards model, Autoimmune hepatitis, Clinical trial and Obeticholic acid.

His work deals with themes such as Crohn's disease, Incidence, Radiology and Inflammatory bowel disease, which intersect with Primary sclerosing cholangitis. His research investigates the connection with Liver transplantation and areas like Liver disease which intersect with concerns in Steatohepatitis. His Ursodeoxycholic acid research is multidisciplinary, incorporating elements of Budesonide, Phases of clinical research, Primary biliary cirrhosis, Bile acid and Clinical endpoint.

Between 2018 and 2021, his most popular works were:

  • Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis (46 citations)
  • Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis (46 citations)
  • Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. (46 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Gideon M. Hirschfield mostly deals with Internal medicine, Gastroenterology, Primary sclerosing cholangitis, Liver transplantation and Cholestasis. His research related to Hazard ratio, Proportional hazards model, Ursodeoxycholic acid, Interquartile range and Cohort might be considered part of Internal medicine. His Gastroenterology study combines topics in areas such as Retrospective cohort study, Autoimmune hepatitis and Bile acid.

Primary sclerosing cholangitis is the subject of his research, which falls under Pathology. His research on Cholestasis also deals with topics like

  • Obeticholic acid and related Disease, Bioinformatics, Sicca syndrome, Asymptomatic and Granulomatous cholangitis,
  • Randomized controlled trial most often made with reference to Clinical trial. The concepts of his Disease study are interwoven with issues in Liver disease, Tacrolimus and Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

C-reactive protein: a critical update

Mark B. Pepys;Gideon M. Hirschfield.
Journal of Clinical Investigation (2003)

4800 Citations

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

John Danesh;Jeremy G. Wheeler;Gideon M. Hirschfield;Shinichi Eda.
The New England Journal of Medicine (2004)

3928 Citations

The gut microbiota and host health: a new clinical frontier

Julian Roberto Marchesi;David H. Adams;Francesca Fava;Gerben D. A. Hermes.
Gut (2016)

1355 Citations

Targeting C-reactive protein for the treatment of cardiovascular disease

Mark B Pepys;Gideon M Hirschfield;Glenys A Tennent;J Ruth Gallimore.
Nature (2006)

789 Citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser.
The New England Journal of Medicine (2016)

645 Citations

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Gideon M. Hirschfield;Xiangdong Liu;Chun Xu;Yue Lu.
The New England Journal of Medicine (2009)

623 Citations

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield;Ulrich Beuers;Christophe Corpechot;Pietro Invernizzi.
Journal of Hepatology (2017)

561 Citations

Primary sclerosing cholangitis

Gideon M Hirschfield;Tom H Karlsen;Tom H Karlsen;Keith D Lindor;David H Adams.
The Lancet (2013)

498 Citations

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

Gideon M. Hirschfield;Andrew Mason;Velimir Luketic;Velimir Luketic;Keith Lindor;Keith Lindor.
Gastroenterology (2015)

490 Citations

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.

John C Chambers;John C Chambers;John C Chambers;Weihua Zhang;Weihua Zhang;Joban S. Sehmi;Joban S. Sehmi;Xinzhong Li.
Nature Genetics (2011)

457 Citations

Editorial Boards

Journal of Hepatology
(Impact Factor: 30.083)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gideon M. Hirschfield

M. Eric Gershwin

M. Eric Gershwin

University of California, Davis

Publications: 155

Tom H. Karlsen

Tom H. Karlsen

Oslo University Hospital

Publications: 90

Pietro Invernizzi

Pietro Invernizzi

University of Milano-Bicocca

Publications: 89

Keith D. Lindor

Keith D. Lindor

Arizona State University

Publications: 89

Gordon D.O. Lowe

Gordon D.O. Lowe

University of Glasgow

Publications: 76

Ulrich Beuers

Ulrich Beuers

University of Amsterdam

Publications: 67

Patrick S.C. Leung

Patrick S.C. Leung

University of California, Davis

Publications: 66

David Jones

David Jones

Newcastle University

Publications: 63

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 63

Michael Trauner

Michael Trauner

Medical University of Vienna

Publications: 62

Ansgar W. Lohse

Ansgar W. Lohse

Universität Hamburg

Publications: 54

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 52

Dimitrios P. Bogdanos

Dimitrios P. Bogdanos

RMIT University

Publications: 52

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 51

Carlo Selmi

Carlo Selmi

Humanitas University

Publications: 46

Andre Franke

Andre Franke

Kiel University

Publications: 42

Trending Scientists

Roberto Segala

Roberto Segala

University of Verona

Tetsuo Tomiyama

Tetsuo Tomiyama

International Professional University of Technology in Tokyo

Maija Tenkanen

Maija Tenkanen

University of Helsinki

C.E. Brion

C.E. Brion

University of British Columbia

Gary S. Sayler

Gary S. Sayler

University of Tennessee at Knoxville

Thomas W. Jungi

Thomas W. Jungi

University of Bern

Esther van der Knaap

Esther van der Knaap

University of Georgia

Antonio Costa

Antonio Costa

National Institute of Geophysics and Volcanology

Simone Rossi

Simone Rossi

University of Siena

Ad J. F. M. Kerkhof

Ad J. F. M. Kerkhof

Vrije Universiteit Amsterdam

Kathryn Osann

Kathryn Osann

University of California, Irvine

Donald A. Berry

Donald A. Berry

The University of Texas MD Anderson Cancer Center

Gad Cotter

Gad Cotter

Durham University

Nehmat Houssami

Nehmat Houssami

University of Sydney

Daniel E. Vanden Berk

Daniel E. Vanden Berk

Saint Vincent College

Something went wrong. Please try again later.